Recommendations for screening for depression in adults

JAMA - Journal of the American Medical Association

Volumn 315, Issue 4, 2016, Pages 349-350

  Thase, Michael E ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Corporal Michael J Crescenz VAMC ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVISORY COMMITTEE; AMBULATORY CARE; DEPRESSION; DIAGNOSIS; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; EDINBURGH POSTNATAL DEPRESSION SCALE; EDITORIAL; HIGH RISK POPULATION; HUMAN; MAJOR DEPRESSION; MENTAL HEALTH CARE; MORBIDITY; MORTALITY; PATIENT HEALTH QUESTIONNAIRE 9; PATIENT REFERRAL; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIMARY HEALTH CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK REDUCTION; SCREENING TEST; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SUICIDE; THERAPY; UNITED STATES;

ADULT; ADVISORY COMMITTEES; DEPRESSION; DIAGNOSIS; HUMANS; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; SENSITIVITY AND SPECIFICITY; SURVEYS AND QUESTIONNAIRES; THERAPY; UNITED STATES;

EID: 84964260994     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.18406     Document Type: Editorial

References (14)

1. Pignone MP, Gaynes BN, Rushton JL, et al. Screening for depression in adults: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2002;136(10):765-776.
2. US Preventive Services Task Force. Screening for depression in adults: US Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2009;151(11):784-792.
3. Siu AL; US Preventive Services Task Force. Screening for depression in adults: US Preventive Services Task Force Recommendation Statement. JAMA. doi:10.1001/jama.2015.18392.
4. Coventry PA, Hudson JL, Kontopantelis E, et al. Characteristics of effective collaborative care for treatment of depression: a systematic review and meta-regression of 74 randomised controlled trials. PLoS One. 2014;9(9):e108114.
5. Gaynes BN, Rush AJ, Trivedi MH, et al. Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR∗D. J Gen Intern Med. 2008; 23(5):551-560.
6. Thase ME. The small specific effects of antidepressants in clinical trials: what do they mean to psychiatrists? Curr Psychiatry Rep. 2011;13(6): 476-482.
7. Thase ME. Using biomarkers to predict treatment response in major depressive disorder: evidence from past and present studies. Dialogues Clin Neurosci. 2014;16(4):539-544.
8. ThaseME, Larsen KG, Kennedy SH. Assessing the "true" effect of active antidepressant therapy v placebo in major depressive disorder: use of a mixture model. Br J Psychiatry. 2011;199(6):501-507.
9. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-levelmeta-analysis. JAMA. 2010; 303(1):47-53.
10. Steidtmann D, Manber R, Arnow BA, et al. Patient treatment preference as a predictor of response and attrition in treatment for chronic depression. Depress Anxiety. 2012;29(10):896-905.
11. Gelenberg AJ. A review of the current guidelines for depression treatment. J Clin Psychiatry. 2010;71 (7):e15.
12. Parikh SV, Segal ZV, Grigoriadis S, et al; Canadian Network for Mood and Anxiety Treatments (CANMAT). Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults: II, Psychotherapy alone or in combination with antidepressant medication. J Affect Disord. 2009;117(suppl 1):S15-S25.
13. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR∗D report. Am J Psychiatry. 2006;163 (11):1905-1917.
14. Szegedi A, JansenWT, van Willigenburg AP, van der Meulen E, Stassen HH, Thase ME. Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: ameta-analysis including 6562 patients. J Clin Psychiatry. 2009;70(3):344-353.